Iterative evaluation of novel access techniques for small bowel obstruction: combining image guided, percutaneous, and endoscopic methods.
Colon and Rectal Devices
Endoscopy
Exploration Study
Laparoscopy
Minimally Invasive Surgical Procedures
Journal
BMJ surgery, interventions, & health technologies
ISSN: 2631-4940
Titre abrégé: BMJ Surg Interv Health Technol
Pays: England
ID NLM: 101764673
Informations de publication
Date de publication:
2023
2023
Historique:
received:
29
04
2022
accepted:
25
04
2023
medline:
24
5
2023
pubmed:
24
5
2023
entrez:
24
5
2023
Statut:
epublish
Résumé
To avoid the need for extensive adhesiolysis in patients with small bowel obstruction (SBO). We evaluated the feasibility of using advanced imaging, percutaneous access, and endoscopy as alternative therapies for SBO. Retrospective case series (IDEAL [Idea, Development, Exploration, Assessment, and Long-term Study Collaborative] stages 1 and 2a). Single tertiary referral center. Twelve adults with chronic SBO resulting from inflammatory bowel disease, disseminated cancer, radiation, and/or adhesive disease. Participants were included if they underwent one of three novel access procedures. There were no exclusion criteria. The median age of participants was 67.5 years (range 42-81); two-thirds were women; and median American Society of Anesthesiology class was 3. All participants underwent one of three novel access methods, followed by wire-guided balloon dilation of a narrowed area of small bowel. These methods combined endoscopic, fluoroscopic, and surgical techniques. The techniques were (1) a purely endoscopic approach aided by an over-the-scope double-balloon device, (2) a combined endoscopic and percutaneous approach, and (3) a cut-down approach. Procedural success (defined as successful access to the small bowel and successful balloon dilation of the stenotic area). Secondary outcomes included major complications, recurrence, length of stay, and procedure time. Procedural success was achieved in 10 of 12 patients (83%). At the time of median follow-up of 10 months, recurrence of SBO was observed in two patients. In only one patient, the novel method did not change the treatment plan. No major complications occurred. Conventional operative intervention was avoided in all patients who achieved technical success with one of the novel approaches. The median postprocedure length of hospital stay was 4 days. Median procedure time was 135 min. Novel minimally invasive approaches to SBO represent feasible alternatives to surgical procedures in select patients. Further study should compare these approaches to standard ones as new methods are refined.
Identifiants
pubmed: 37223824
doi: 10.1136/bmjsit-2022-000150
pii: bmjsit-2022-000150
pmc: PMC10201263
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e000150Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: Art Sedrakyan is an Editor-in-Chief of this journal.
Références
Ann Surg. 2004 Aug;240(2):193-201
pubmed: 15273540
Surg Endosc. 2019 Oct;33(10):3209-3217
pubmed: 30460502
N Engl J Med. 2014 May 8;370(19):1790-8
pubmed: 24678937
J Clin Gastroenterol. 2005 Apr;39(4):284-90
pubmed: 15758621
Lancet. 2005 Jun 25-Jul 1;365(9478):2179-86
pubmed: 15978925
Tech Coloproctol. 2020 Dec;24(12):1271-1276
pubmed: 32757156
Int J Surg. 2019 Jul;67:18-23
pubmed: 30849526
World J Gastroenterol. 2017 Nov 7;23(41):7397-7406
pubmed: 29151693
Surg Endosc. 2019 Jan;33(1):315-321
pubmed: 30014326
Int J Surg. 2017 Sep;45:58-66
pubmed: 28728984
BMC Surg. 2011 Jun 09;11:13
pubmed: 21658255
Gut Liver. 2014 Jul;8(4):394-9
pubmed: 25071904
Inflamm Bowel Dis. 2016 Feb;22(2):380-6
pubmed: 26535767
Surg Laparosc Endosc Percutan Tech. 2008 Dec;18(6):565-8
pubmed: 19098661